Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Average Rating of “Buy” from Analysts

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) has received a consensus recommendation of “Buy” from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and three have given a strong buy recommendation to the company.

RBGLY has been the topic of several recent analyst reports. Barclays lowered shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a report on Tuesday, February 4th. HSBC upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada restated an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th. Finally, Hsbc Global Res upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th.

View Our Latest Stock Report on RBGLY

Reckitt Benckiser Group Stock Performance

OTCMKTS RBGLY opened at $13.45 on Monday. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47. The stock’s fifty day moving average is $13.12 and its two-hundred day moving average is $12.55. Reckitt Benckiser Group has a fifty-two week low of $10.24 and a fifty-two week high of $14.10.

Reckitt Benckiser Group Increases Dividend

The company also recently announced a dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 11th will be paid a dividend of $0.2909 per share. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.19. The ex-dividend date is Friday, April 11th.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

See Also

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.